Biostate AI connects samples, data, and decisions to redefine precision health.
Total raised: $16M
Funding Rounds 2
| Date | Series | Amount | Investors |
| 21.05.2025 | Series A | $12M | - |
| 12.07.2024 | - | $4M | - |
Mentions in press and media 15
| Date | Title | Description |
| 18.09.2025 | Biostate AI’s K-Dense accelerates scientific research cycles with AI | - |
| 18.09.2025 | Biostate AI Launches K-Dense Beta, an AI Agent That Compresses Research Cycles from Years to Days; Validated with Harvard Longevity Discovery Breakthrough | Biostate AI, a company accelerating biological research through innovative AI models, announced the launch of Beta, a comprehensive multi-agent AI research system that can compress research cycles from years to days, while eliminating hallu... |
| 21.05.2025 | Biostate AI: Revolutionizing Molecular Diagnostics with a $12M Boost | In the world of molecular diagnostics, a new player is making waves. Biostate AI has secured $12 million in Series A funding, led by Accel. This investment is not just a financial boost; it’s a lifeline for a company aiming to reshape the l... |
| 21.05.2025 | Biostate AI Raises $12M in Series A Funding | Biostate AI, a Houston, TX-based artificial intelligence and RNA sequencing company, raised $12M in Series A funding. The round was led by Accel with participation from Gaingels, Mana Ventures, InfoEdge Ventures, Matter Venture Partners, Vi... |
| 21.05.2025 | Deeptech startup Biostate AI raises $12 million in led by Accel, others | Biostate AI, a deeptech startup working at the intersection of artificial intelligence and RNA sequencing, has raised $12 million in a Series A funding round led by venture capital firm Accel, with participation from Gaingels, Mana Ventures... |
| 21.05.2025 | Biostate AI Raises USD 12 Mn Series A Led by Accel The company plans to deepen its dataset, expand collaborations in oncology, autoimmune, and cardiovascular research, and improve its predictive model... | Biostate AI has raised USD 12 million in a Series A funding round led by Accel, with participation from Gaingels, Mana Ventures, InfoEdge Ventures, and returning investors Matter Venture Partners, Vision Plus Capital, and Catapult Ventures.... |
| 20.05.2025 | Biostate AI Secures $12M to Optimize RNA Sequencing, Precision Medicine | What You Should Know: – Biostate AI, an innovator at the intersection of artificial intelligence and RNA sequencing raises $12M in Series A funding spearheaded by Accel, with participation from Gaingels, Mana Ventures, InfoEdge Ventures, an... |
| 20.05.2025 | Biostate AI closes $12M to bring the Netflix model to molecular diagnostics | The company is reimagining the fragmented reality of molecular research by building the world’s largest RNA sequencing dataset. This dataset will train a general-purpose AI to understand—and eventually guide therapies for—all human diseases... |
| 13.07.2024 | Biostate AI: Revolutionizing Biodata Analysis | Biostate AI, a Palo Alto-based startup, is making waves in the world of biodata analysis. With a recent funding round of over $4 million led by Matter Venture Partners, the company is poised to expand its operations and development efforts.... |
| 12.07.2024 | High-tech Formula 1 cars rev engines toward Houston for unique event | Houstonians with a passion for Formula 1 racing have to drive to Austin — and spend a lot of money — to get up close to the innovative cars that reach speeds over 200 miles per hour. That’s all going to change in September. The Bayou City w... |
Show more